Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berk

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Translational Psychiatry|January 14, 2015
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acidsG P Amminger, A Mechelli, S Rice, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 21, 2015
Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trialP Conus, M Berk, S M Cotton, et al.
Acta Neuropsychiatrica|July 12, 2016
The impact of age at onset of bipolar 1 disorder on functioning and clinical presentationF Biffin, S Tahtalian, K Filia, et al.
Acta Psychiatrica Scandinavica. Supplementum|April 10, 2009
Clinical practice recommendations for bipolar disorderG S Malhi, D Adams, L Lampe, et al.
Translational Psychiatry|August 19, 2015
The use of statins for the treatment of depression in patients with acute coronary syndromeS W Kim, K Y Bae, J M Kim, et al.
Schizophrenia Research|September 23, 2011
Depressive symptoms in first episode schizophrenia spectrum disorderS M Cotton, M Lambert, B G Schimmelmann, et al.
Journal of Affective Disorders|March 22, 2015
Online mindfulness-based intervention for late-stage bipolar disorder: pilot evidence for feasibility and effectivenessG Murray, N D Leitan, M Berk, et al.
Psychological Medicine|May 20, 2016
Bias in emerging biomarkers for bipolar disorderA F Carvalho, C A Köhler, B S Fernandes, et al.
Molecular Psychiatry|December 21, 2011
Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individualsG P Amminger, M R Schäfer, C M Klier, et al.
Journal of Affective Disorders|August 31, 2010
N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trialP V Magalhães, O M Dean, A I Bush, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Translational Psychiatry|January 14, 2015
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acidsG P Amminger, A Mechelli, S Rice, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 21, 2015
Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trialP Conus, M Berk, S M Cotton, et al.
Acta Neuropsychiatrica|July 12, 2016
The impact of age at onset of bipolar 1 disorder on functioning and clinical presentationF Biffin, S Tahtalian, K Filia, et al.
Acta Psychiatrica Scandinavica. Supplementum|April 10, 2009
Clinical practice recommendations for bipolar disorderG S Malhi, D Adams, L Lampe, et al.
Translational Psychiatry|August 19, 2015
The use of statins for the treatment of depression in patients with acute coronary syndromeS W Kim, K Y Bae, J M Kim, et al.
Schizophrenia Research|September 23, 2011
Depressive symptoms in first episode schizophrenia spectrum disorderS M Cotton, M Lambert, B G Schimmelmann, et al.
Journal of Affective Disorders|March 22, 2015
Online mindfulness-based intervention for late-stage bipolar disorder: pilot evidence for feasibility and effectivenessG Murray, N D Leitan, M Berk, et al.
Psychological Medicine|May 20, 2016
Bias in emerging biomarkers for bipolar disorderA F Carvalho, C A Köhler, B S Fernandes, et al.
Molecular Psychiatry|December 21, 2011
Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individualsG P Amminger, M R Schäfer, C M Klier, et al.
Journal of Affective Disorders|August 31, 2010
N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trialP V Magalhães, O M Dean, A I Bush, et al.
Pageof 24